Aytu BioPharma, Inc. (AYTU) vs TherapeuticsMD, Inc. (TXMD)

Aytu BioPharma, Inc. and TherapeuticsMD, Inc. are both Drug Manufacturers Specialty & Generic companies. Aytu BioPharma, Inc. and TherapeuticsMD, Inc. are of similar size ($25.1M and $24.7M). TherapeuticsMD, Inc. grew revenue faster over the last twelve months: 27.8% against −13.3%. TherapeuticsMD, Inc. has the higher net margin (−6.64% vs −24.8%) and the higher return on invested capital (−13.8% vs −20.0%). Across the 19 metrics below, TherapeuticsMD, Inc. leads on 11 and Aytu BioPharma, Inc. on 8.

Valuation

Metric AYTU TXMD Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.48 7.26 2.25
P/B 0.78 0.87 1.90
Price to free cash flow 8.53 8.72 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.32 6.95 2.56
Earnings yield (51.16%) (1.14%) (2.99%)
Free cash flow yield 11.72% 11.47% 0.00%

Profitability

Metric AYTU TXMD Drug Manufacturers Specialty & Generic median
Gross margin 63.95% 100.00% 53.94%
Operating margin (14.44%) (120.89%) 0.00%
Net margin (24.76%) (6.64%) 0.00%
Free cash flow margin 5.62% 94.71% 0.00%
Return on equity (52.55%) (0.80%) (0.40%)
Return on assets (12.44%) (0.57%) (3.32%)
Return on invested capital (19.99%) (13.77%) 0.00%

Growth

Metric AYTU TXMD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (13.27%) 27.78% 10.01%
EPS growth (last fiscal year) 46.44% 73.68% —
Revenue growth, 5-year CAGR (2.59%) (45.84%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AYTU TXMD Drug Manufacturers Specialty & Generic median
Debt to equity 0.48 0.00 0.05
Current ratio 1.13 3.22 2.31
Net debt to EBITDA 2.17 2.34 0.85

Dividend

Metric AYTU TXMD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AYTU TXMD Drug Manufacturers Specialty & Generic median
Market cap 25.10m 24.65m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack